The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems

Neuroscience and Biobehavioral Reviews

Volumn 28, Issue 4, 2004, Pages 415-431

  Adell, Albert ^a   Artigas, Francesc ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

Acetylcholine; Dopamine; GABA; Glutamate; Interaction; Noradrenaline; Serotonin; Somatodendritic release; Ventral tegmental area

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPHETAMINE; CALCIUM; COCAINE; DIZOCILPINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NORADRENALIN; POTASSIUM; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A ANTAGONIST; TETRODOTOXIN; TYROSINE 3 MONOOXYGENASE; VERATRIDINE;

ANTIBODY LABELING; BRAIN NERVE CELL; DEPOLARIZATION; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; ENZYME SYNTHESIS; HYPERPOLARIZATION; IMMUNOCOMPETENT CELL; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; MESENCEPHALON; NONHUMAN; NUCLEUS ACCUMBENS; PATHOGENESIS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SCHIZOPHRENIA; VENTRAL TEGMENTUM;

EID: 4043141566     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2004.05.001     Document Type: Article

References (287)

1. Björklund A., Lindvall O. Dopamine-containing systems in the CNS. Björklund A., Hökfelt T. Handbook of chemical neuroanatomy. Classical transmitters in the CNS. vol. 2:1984;55-122 Elsevier, Amsterdam
2. Albanese A., Minciacchi D. Organization of the ascending projections from the ventral tegmental area: a multiple fluorescent retrograde tracer study in the rat. J Comp Neurol. 216:1983;406-420
3. Sesack S.R., Snyder C.L., Lewis D.A. Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol. 363:1995;264-280
4. Krimer L.S., Jakab R.L., Goldman-Rakic P.S. Quantitative three-dimensional analysis of the catecholaminergic innervation of identified neurons in the macaque prefrontal cortex. J Neurosci. 17:1997;7450-7461
5. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev. 71:1991;155-234
6. Schultz W. Predictive reward signal of dopamine neurons. J Neurophysiol. 80:1998;1-27
7. Spanagel R., Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22:1999;521-527
8. Williams S.M., Goldman-Rakic P.S. Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex. 8:1998;321-345
9. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci. 21:2001;1787-1794
10. Berridge C.W., Stalnaker T.A. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex. Synapse. 46:2002;140-149
11. Pei Q., Zetterström T., Fillenz M. Tail pinch-induced changes in the turnover and release of dopamine and 5-hydroxytryptamine in different brain regions of the rat. Neuroscience. 35:1990;133-138
12. Sorg B.A., Kalivas P.W. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 53:1993;695-703
13. Finlay J.M., Zigmond M.J., Abercrombie E.D. Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: effects of diazepam. Neuroscience. 64:1995;619-628
14. Del Arco A., Mora F. Dopamine release in the prefrontal cortex during stress is reduced by the local activation of glutamate receptors. Brain Res Bull. 56:2001;125-130
15. Moghaddam B., Bunney B.S. Differential effect of cocaine on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens: comparison to amphetamine. Synapse. 4:1989;156-161
16. Kuhar M.J., Ritz M.C., Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302
17. 1 opioid receptor mechanism. Science. 276:1997;2048-2050
18. Volkow N.D., Fowler J.S., Wang G.J., Goldstein R.Z. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 78:2002;610-624
19. Davis K.L., Kahn R.S., Ko G., Davidson M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry. 148:1991;1474-1486
20. Goldstein M., Deutch A.Y. Dopaminergic mechanisms in the pathogenesis of schizophrenia. FASEB J. 6:1992;2413-2421
21. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol. 41:2001;237-260
22. Tzschentke T.M. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol. 63:2001;241-320
23. Mattay V.S., Tessitore A., Callicott J.H., Bertolino A., Goldberg T.E., Chase T.N., Hyde T.M., Weinberger D.R. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol. 51:2002;156-164
24. McLennan H. The release of dopamine from the putamen. Experientia. 21:1965;725-726
25. Vrbanac J.J., Tilson H.A., Moore K.E., Rech R.H. Comparison of 2,5-dimethoxy-4-methylamphetamine (DOM) and D-amphetamine for in vivo efflux of catecholamines from rat brain. Pharmacol Biochem Behav. 3:1975;57-64
26. Korf J., Zieleman M., Westerink B.H.C. Dopamine release in substantia nigra? Nature. 260:1976;257-258
27. Geffen L.B., Jessell T.M., Cuello A.C., Iversen L.L. Release of dopamine from dendrites in rat substantia nigra. Nature. 260:1976;258-260
28. Nieoullon A., Cheramy A., Glowinski J. Release of dopamine in vivo from cat substantia nigra. Nature. 266:1977;375-377
29. Cheramy A., Leviel V., Glowinski J. Dendritic release of dopamine in the substantia nigra. Nature. 289:1981;537-542
30. Beart P.M., McDonald D. 5-Hydroxytryptamine and 5-hydroxytryptaminergic- dopaminergic interactions in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 34:1982;591-593
31. Bernardini G.L., Gu X., Viscardi E., German D.C. Amphetamine-induced and spontaneous release of dopamine from A9 and A10 cell dendrites: an in vitro electrophysiological study in the mouse. J Neural Transm Gen Sect. 84:1991;183-193
32. Guan X.M., McBride W.J. Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull. 23:1989;541-547
33. Bradberry C.W., Roth R.H. Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis. Neurosci Lett. 103:1989;97-102
34. Kalivas P.W., Bourdelais A., Abhold R., Abbott L. Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 region. Neurosci Lett. 100:1989;215-219
35. Kalivas P.W., Duffy P. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem. 56:1991;961-967
36. Yoshida M., Yokoo H., Mizoguchi K., Kawahara H., Tsuda A., Nishikawa T., Tanaka M. Eating and drinking cause increased dopamine release in the nucleus accumbens and ventral tegmental area in the rat: measurement by in vivo microdialysis. Neurosci Lett. 139:1992;73-76
37. Zhang H., Kiyatkin E.A., Stein E.A. Behavioral and pharmacological modulation of ventral tegmental dendritic dopamine release. Brain Res. 656:1994;59-70
38. Wang R.Y. Dopaminergic neurons in the rat ventral tegmental area. III. Effects of D- and L-amphetamine. Brain Res Rev. 3:1981;153-165
39. White F.J., Wang R.Y. A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci. 34:1984;1161-1170
40. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev. 18:1993;75-113
41. Halliday G.M., Tork I. Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human. J Comp Neurol. 252:1986;423-445
42. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull. 9:1982;321-353
43. German D.C., Manaye K.F. Midbrain dopaminergic neurons (nuclei A8, A9, and A10). Three-dimensional reconstruction in the rat. J Comp Neurol. 331:1993;297-309
44. Carr D.B., Sesack S.R. GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse. 38:2000;114-123
45. Beckstead R.M., Domesick V.B., Nauta W.J.H. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175:1979;191-217
46. Hökfelt T., Mårtensson R., Björklund A., Kleinau S., Goldstein M. Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. Björklund A., Hökfelt T. Handbook of chemical neuroanatomy. Classical transmitters in the CNS. vol. 2:1984;277-379 Elsevier, Amsterdam
47. Fallon J.H., Loughlin S.E. Substantia nigra. Paxinos G. The rat nervous system. 1995;215-237 Academic Press, San Diego
48. Rice M.E., Richards C.D., Nedergaard S., Hounsgaard J., Nicholson C., Greenfield S.A. Direct monitoring of dopamine and 5-HT release in substantia nigra and ventral tegmental area in vitro. Exp Brain Res. 100:1994;395-406
49. Doherty M.D., Pickel V.M. Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area. Brain Res. 864:2000;176-185
50. Bayer V.E., Pickel V.M. Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabelling density and neuronal associations. J Neurosci. 10:1990;2996-3013
51. Van Bockstaele E.J., Cestari D.M., Pickel V.M. Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons. Brain Res. 647:1994;307-322
52. Nirenberg M.J., Chan J., Liu Y., Edwards R.H., Pickel V.M. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J Neurosci. 16:1996;4135-4145
53. Pickel V.M., Chan J., Nirenberg M.J. Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse. 45:2002;113-124
54. Mercer L., del Fiacco M., Cuello A.C. The smooth endoplasmic reticulum as a possible storage site for dendritic dopamine in substantia nigra neurones. Experientia. 35:1979;101-103
55. Heeringa M.J., Abercrombie E.D. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release. J Neurochem. 65:1995;192-200
56. Biggs C.S., Fowler L.J., Whitton P.S., Starr M.S. NMDA receptor antagonists increase the release of dopamine in the substantia nigra of reserpine-treated rats. Eur J Pharmacol. 299:1996;83-91
57. Adell A., Artigas F. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. Br J Pharmacol. 125:1998;1361-1367
58. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J Neurosci. 13:1993;276-284
59. Iravani M.M., Muscat R., Kruk Z.L. Comparison of somatodendritic and axon terminal dopamine release in the ventral tegmental area and the nucleus accumbens. Neuroscience. 70:1996;1025-1037
60. Chen N.H., Reith M.E.A. Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J Neurochem. 63:1994;1701-1713
61. Cragg S.J., Greenfield S.A. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum. J Neurosci. 17:1997;5738-5746
62. Reith M.E.A., Li M.-Y., Yan Q.-S. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology. 134:1997;309-317
63. Campbell A.D., Kohl R.R., McBride W.J. Serotonin-3 receptor and ethanol-stimulated somatodendritic dopamine release. Alcohol. 13:1996;569-574
64. Llinás R., Greenfield S.A., Jahnsen H. Electrophysiology of pars compacta cells in the in vitro substantia nigra - a possible mechanism for dendritic release. Brain Res. 294:1984;127-132
65. Grace A.A. Evidence for the functional compartmentalization of spike generating regions of rat midbrain dopamine neurons recorded in vitro. Brain Res. 524:1990;31-41
66. Mathé J.M., Nomikos G.G., Blakeman K.H., Svensson T.H. Differential actions of dizocilpine (MK-801) on the mesolimbic and mesocortical dopamine systems: role of neuronal activity. Neuropharmacology. 38:1999;121-128
67. Cragg S.J., Rice M.E., Greenfield S.A. Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum. J Neurophysiol. 77:1997;863-873
68. Rice M.E., Cragg S.J., Greenfield S.A. Characteristics of electrically evoked somatodendritic dopamine release in substantia nigra and ventral tegmental area in vitro. J Neurophysiol. 77:1997;853-862
69. Chen B.T., Rice M.E. Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J Neurochem. 81:2002;158-169
70. Santiago M., Westerink B.H.C. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J Neurochem. 57:1991;738-747
71. Robertson G.S., Damsma G., Fibiger H.C. Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J Neurosci. 11:1991;2209-2216
72. Adell A., Celada P., Abellán M.T., Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res Rev. 39:2002;154-180
73. Koob G.F. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci. 13:1992;177-184
74. Parsons L.H., Justice J.B. Jr. Serotonin and dopamine sensitization in the nucleus accumbens, ventral tegmental area, and dorsal raphe nucleus following repeated cocaine administration. J Neurochem. 61:1993;1611-1619
75. Shoblock J.R., Sullivan E.B., Maisonneuve I.M., Glick S.D. Neurochemical and behavioral differences between D-methamphetamine and D-amphetamine in rats. Psychopharmacology. 165:2003;359-369
76. Chen N.H., Reith M.E.A. Role of axonal and somatodendritic monoamine transporters in action of uptake blockers. Reith M.E.A. Neurotransmitter transporter: structure, function, and regulation. 1997;345-391 Humana Press, Totowa, NJ
77. 3H]GBR 12935. Eur J Pharmacol. 126:1986;171-173
78. 3H-GBR 12935. J Neural Transm Gen Sect. 87:1992;1-14
79. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., Levey A.I. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci. 15:1995;1714-1723
80. Freed C., Revay R., Vaughan R.A., Kriek E., Grant S., Uhl G.R., Kuhar M.J. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol. 359:1995;340-349
81. Nirenberg M.J., Chan J., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci. 17:1997;5255-5262
82. Giros B., El Mestikawy S., Bertrand L., Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295:1991;149-154
83. Shimada S., Kitayama S., Walther D., Uhl G. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Mol Brain Res. 13:1992;359-362
84. Blanchard V., Raisman-Vozari R., Vyas S., Michel P.P., Javoy-Agid F., Uhl G., Agid Y. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Mol Brain Res. 22:1994;29-38
85. 2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience. 63:1994;357-362
86. Shilling P.D., Kelsoe J.R., Segal D.S. Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats. Neurosci Lett. 236:1997;131-134
87. 3H]GBR 12935: binding characteristics. Brain Res. 540:1991;1-13
88. Li M.-Y., Yan Q.-S., Coffey L.L., Reith M.E.A. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats following focal cocaine and other monoamine uptake blockers. J Neurochem. 66:1996;559-568
89. Kalivas P.W., Duffy P. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci. 1993;266-275
90. Miller G.W., Gainetdinov R.R., Levey A.I., Caron M.G. Dopamine transporters and neuronal injury. Trends Pharmacol Sci. 20:1999;424-429
91. Gainetdinov R.R., Sotnikova T.D., Caron M.G. Monoamine transporter pharmacology and mutant mice. Trends Pharmacol Sci. 23:2002;67-73
92. Jones S.R., Gainetdinov R.R., Jaber M., Giros B., Wightman R.M., Caron M.G. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA. 95:1998;4029-4034
93. Benoit-Marand M., Jaber M., Gonon F. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences. Eur J Neurosci. 12:2000;2985-2992
94. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612
95. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46:1990;635-645
96. Pacholczyk T., Blakely R.D., Amara S.G. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature. 350:1991;350-354
97. Mansour A., Meador-Woodruff J.H., Zhou Q., Civelli O., Akil H., Watson S.J. Jr. A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience. 46:1992;959-971
98. 1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand. Neuroscience. 26:1988;83-100
99. Wamsley J.K., Gehlert D.R., Filloux F.M., Dawson T.M. Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain. J Chem Neuroanat. 2:1989;119-137
100. Ariano M.A. Distribution of dopamine receptors. Neve K.A., Neve R.L. The dopamine receptors. 1997;77-103 Humana Press, Totowa, NJ
101. 5, but not progestin receptor, antagonist and anti-sense oligonucleotide infusions to the ventral tegmental area of cycling rats and hamsters attenuate lordosis. Behav Brain Res. 103:1999;23-34
102. 5 receptor immunolocalization in the rat and monkey brain. Synapse. 37:2000;125-145
103. Cameron D.L., Williams J.T. Dopamine D1 receptors facilitate transmitter release. Nature. 366:1993;344-347
104. Lu X.Y., Churchill L., Kalivas P.W. Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area. Synapse. 25:1997;205-214
105. 1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci. 15:1995;5379-5388
106. Ranaldi R., Wise R.A. Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J Neurosci. 21:2001;5841-5846
107. Rahman S., McBride W.J. Feedback control of mesolimbic somatodendritic dopamine release in rat brain. J Neurochem. 74:2000;684-692
108. Rahman S., McBride W.J. D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA). J Neurochem. 77:2001;1248-1255
109. 125I]iodosulpride. Neuroscience. 20:1987;117-155
110. 2 receptor binding sites in the rat brain and pituitary: an in situ hybridization receptor autoradiographic analysis. J Neurosci. 10:1990;2587-2600
111. 2 dopamine receptor mRNA in brain of normal mice and mice lesioned with 6-hydroxydopamine. Neuropharmacology. 30:1991;927-941
112. 2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci. 14:1994;88-106
113. 2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J Comp Neurol. 362:1995;400-410
114. 2 receptor deficient mice. Neuroscience. 79:1997;323-327
115. 3 receptors expressed by all mesencephalic dopamine neurons. J Neurosci. 20:2000;8677-8684
116. 3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. Eur J Pharmacol. 275:1995;R7-R9
117. 3) as a target for neuroleptics. Nature. 347:1990;146-151
118. Meador-Woodruff J.H., Damask S.P., Watson S.J. Jr. Differential expression of autoreceptors in the ascending dopamine systems of the human brain. Proc Natl Acad Sci USA. 91:1994;8297-8301
119. Grace A.A. Dopamine. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology: the fifth generation of progress. 2002;119-132 Lippincott/Williams & Wilkins, Philadelphia, PA
120. Kohl R.R., Katner J.S., Chernet E., McBride W.J. Ethanol and negative feedback regulation of mesolimbic dopamine release in rats. Psychopharmacology. 139:1998;79-85
121. Chen N.N.H., Pan W.H.T. Regulatory effects of D2 receptors in the ventral tegmental area on the mesocorticolimbic dopaminergic pathway. J Neurochem. 74:2000;2576-2582
122. Westerink B.H.C., Kwint H.F., de Vries J.B. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci. 16:1996;2605-2611
123. Westerink B.H.C., Enrico P., Feimann J., de Vries J.B. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther. 285:1998;143-154
124. 2-like receptors inhibit excitatory transmission onto rat ventral tegmental dopaminergic neurones. J Physiol. 523:2000;163-173
125. Hervé D., Pickel V.M., Tong H.J., Beaudet A. Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons. Brain Res. 435:1987;71-83
126. Broderick P.A., Phelix C.F. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT-DA interaction in cocaine dysfunctional behavior. Neurosci Biobehav Rev. 21:1997;227-260
127. Vertes R.P., Fortin W.J., Crane A.M. Projections of the median raphe nucleus in the rat. J Comp Neurol. 407:1999;555-582
128. Cragg S.J., Hawkey C.R., Greenfield S.A. Comparison of serotonin and dopamine release in substantia nigra and ventral tegmental area: region and species differences. J Neurochem. 69:1997;2378-2386
129. Cameron D.L., Wessendorf M.W., Williams J.T. A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids. Neuroscience. 77:1997;155-166
130. Gervais J., Rouillard C. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra. Synapse. 35:2000;281-291
131. 1A receptors. Eur J Neurosci. 12:2000;3265-3275
132. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346:1985;205-230
133. 2A receptor mRNA in human brain. Brain Res. 676:1995;157-168
134. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol. 351:1995;357-373
135. Doherty M.D., Pickel V.M. Targeting of serotonin 1A receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain. J Comp Neurol. 433:2001;390-400
136. Steffensen S.C., Svingos A.L., Pickel V.M., Henriksen S.J. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci. 18:1998;8003-8015
137. 1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn-Schmiedeberg's Arch Pharmacol. 347:1993;353-362
138. Prisco S., Pagannone S., Esposito E. Serotonin-dopamine interaction in the rat ventral tegmental area: an electrophysiological study in vivo. J Pharmacol Exp Ther. 271:1994;83-90
139. 1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats. J Pharmacol Exp Ther. 280:1997;1241-1249
140. 1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535. Synapse. 30:1998;172-180
141. Chen N.H., Reith M.E.A. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (±)-8-hydroxy-2-(di-n-propylamino)tetralin. J Neurochem. 64:1995;1585-1597
142. Arborelius L., Nomikos G.G., Hacksell U., Svensson T.H. (R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex. Acta Physiol Scand. 148:1993;465-466
143. 1A agonist (±)-8-OH-DPAT modulates basal and stress-induced changes in medial prefrontal cortical dopamine. Synapse. 18:1994;218-224
144. Tanda G., Carboni E., Frau R., Di Chiara G. Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology. 115:1994;285-288
145. Gobert A., Rivet J.-M., Audinot V., Newman-Tancredi A., Cistarelli L., Millan M.J. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience. 84:1998;413-429
146. 1A receptor activation increases in vivo dopamine release in rat prefrontal cortex. Br J Pharmacol. 129:2000;1028-1034
147. 2A receptors in antipsychotic activity. Life Sci. 56:1995;2209-2222
148. Meltzer H.Y., Li Z., Kaneda Y., Ichikawa J. Serotonin receptors: their key role in drugs to treat schizophrenia. Progr Neuro-Psychopharmacol Biol Psychiatry. 27:2003;1159-1172
149. Cornea-Hébert V., Riad M., Wu C., Singh S.K., Descarries L. Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol. 409:1999;187-209
150. 2A receptors on dopamine cells in subnuclei of the midbrain A10 cell group. Neuroscience. 111:2002;163-176
151. Ikemoto K., Nishimura A., Okado N., Mikuni M., Nishi K., Nagatsu I. Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration. Brain Res. 853:2000;377-380
152. 2C receptors. Mol Brain Res. 23:1994;163-178
153. Pessia M., Jiang Z.-G., North R.A., Johnson S.W. Actions of 5-hydroxytryptamine on ventral tegmental area neurons of the rat in vitro. Brain Res. 654:1994;324-330
154. Millan M.J., Lejeune F., Gobert A. Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents. J Psychopharmacol. 14:2000;114-138
155. 2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study. Synapse. 35:2000;53-61
156. 2C receptors. Brain Res. 865:2000;85-90
157. 2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat. Synapse. 36:2000;205-221
158. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology. 37:1998;953-955
159. Di Giovanni G., Di Matteo V., La Grutta V., Esposito E. m-Chlorophenylpiperazine excites non-dopaminergic neurons in the rat substantia nigra and ventral tegmental area by activating serotonin-2C receptors. Neuroscience. 103:2001;111-116
160. 2C receptor messenger RNA in the basal ganglia of adult rats. J Comp Neurol. 384:1997;233-247
161. Di Giovanni G., De Deurwaerdére P., Di Mascio M., Di Matteo V., Esposito E., Spampinato U. Selective blockade of serotonin-2C/2B receptors enhance mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience. 91:1999;587-597
162. 2C/2B receptors enhances dopamine release in the rat nucleus accumbens. Neuropharmacology. 37:1998;265-272
163. 2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. J Neurochem. 73:1999;1033-1042
164. 2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology. 38:1999;1195-1205
165. 2C) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J Neurochem. 82:2002;93-100
166. 3 receptor antagonists LY277359 and granisetron potentiate the suppressant action of apomorphine on the basal firing rate of ventral tegmental dopamine cells. Eur J Pharmacol. 209:1991;143-150
167. 3 receptor antagonist zatosetron decreases the number of spontaneously active A10 neurons. Eur J Pharmacol. 205:1991;113-116
168. Hervé D., Blanc G., Glowinski J., Tassin J.P. Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat. Brain Res. 237:1982;510-516
169. Grenhoff J., Nisell M., Ferre S., Aston-Jones G., Svensson T.H. Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect. 93:1993;11-25
170. Grenhoff J., North R.A., Johnson S.W. Alpha 1-adrenergic effects on dopamine neurons recorded intracellularly in the rat midbrain slice. Eur J Neurosci. 7:1995;1707-1713
171. Linnér L., Endersz H., Öhman D., Bengtsson F., Schalling M., Svensson T.H. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther. 297:2001;540-546
172. 2C-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience. 84:1998;1085-1096
173. 2-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther. 295:2000;1206-1222
174. Gobbi G., Muntoni A.L., Gessa G.L., Diana M. Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal. Psychopharmacology. 158:2001;1-6
175. Georges F., Aston-Jones G. Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology. 28:2003;1140-1149
176. Matsumoto M., Yoshioka M., Togashi H., Mori K., Ueno K.I., Saito H. Effects of idazoxan on dopamine release in the prefrontal cortex of freely moving rats. Eur J Pharmacol. 343:1998;165-170
177. Hertel P., Nomikos G.G., Svensson T.H. Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level. Eur J Pharmacol. 371:1999;153-158
178. Oakman S.A., Faris P.L., Kerr P.E., Cozzari C., Hartman B.K. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci. 15:1995;5959-5969
179. Blaha C.D., Allen L.F., Das S., Inflis W.L., Latimer M.P., Vincent S.R., Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci. 16:1996;714-722
180. Yeomans J., Baptista M. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain stimulation reward. Pharmacol Biochem Behav. 57:1997;915-921
181. Calabresi P., Lacey M.G., North R.A. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol. 98:1989;135-140
182. Lacey M.G., Calabresi P., North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J Pharmacol Exp Ther. 253:1990;395-400
183. Yeomans J.S. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology. 12:1995;3-16
184. Pidoplichko V.I., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 390:1997;401-404
185. Gronier B., Rasmussen K. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat. Br J Pharmacol. 124:1998;455-464
186. Yeomans J., Forster G., Blaha C. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci. 68:2001;2449-2456
187. Clarke P.B.S., Pert A. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348:1985;355-358
188. Goldner F.M., Dineley K.T., Patrick J.W. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area. Neuroreport. 8:1997;2736-2742
189. Charpantier E., Barneoud P., Moser P., Besnard F., Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Neuroreport. 9:1998;3097-3101
190. Forster G.L., Blaha C.D. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur J Neurosci. 12:2000;3596-3604
191. Azam L., Winzer-Serhan U.H., Chen Y., Leslie F.M. Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. J Comp Neurol. 444:2002;260-274
192. Chen Y., Sharples T.J., Phillips K.G., Benedetti G., Broad L.M., Zwart R., Sher E. The nicotinic α4β2 receptor selective agonist, TC-2559, increases dopamine neuronal activity in the ventral tegmental area of rat midbrain slices. Neuropharmacology. 45:2003;334-344
193. Yin R., French E.D. A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study. Brain Res Bull. 51:2000;507-514
194. Klink R., de Kerchove d'Exaerde A., Zoli M., Changeux J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J Neurosci. 21:2001;1452-1463
195. Schilström B., Fagerquist M.V., Zhang X., Hertel P., Panagis G., Nomikos G.G., Svensson T.H. Putative role of presynaptic α7* nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse. 38:2000;375-383
196. Vilaró M.T., Palacios J.M., Mengod G. Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett. 114:1990;154-159
197. Weiner D.M., Levey A.I., Brann M.R. Expression of muscarinic acetylcholine and dopamine receptors mRNAs in rat basal ganglia. Proc Natl Acad Sci USA. 87:1990;7050-7054
198. Grenhoff J., Aston-Jones G., Svensson T.H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand. 128:1986;351-358
199. Nisell M., Nomikos G.G., Svensson T.H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 16:1994;36-44
200. Nisell M., Nomikos G.G., Svensson T.H. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol. 75:1994;348-352
201. Sziraki I., Sershen H., Hashim A., Lajtha A. Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens. Neurochem Res. 27:2002;253-261
202. Schilström B., Nomikos G.G., Nisell M., Hertel P., Svensson T.H. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience. 82:1998;781-789
203. Grillner P., Svensson T.H. Nicotine-induced excitation of midbrain dopamine neurons in vitro involves ionotropic glutamate receptor activation. Synapse. 38:2000;1-9
204. Gronier B., Perry K.W., Rasmussen K. Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area. Psychopharmacology. 147:2000;347-355
205. Garzón M., Vaughan R.A., Uhl G.R., Kuhar M.J., Pickel V.M. Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter. J Comp Neurol. 410:1999;197-210
206. Kosaka T., Kosaka K., Hataguchi Y., Nagatsu I., Wu J.Y., Ottersen O.P., Storm-Mathisen J., Hama K. Catecholaminergic neurons containing GABA-like and/or glutamate acid decarboxylase-like immunoreactivities in various brain regions of the rat. Exp Brain Res. 66:1987;191-210
207. Bayer V.E., Pickel V.M. GABA-labeled terminals form proportionally more synapses within dopaminergic neurons containing low densities of tyrosine hydroxylase immunoreactivity in rat ventral tegmental area. Brain Res. 559:1991;44-55
208. Kalivas P.W., Striplin C.D., Steketee J.D., Klitenick M.A., Duffy P. Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann NY Acad Sci. 654:1992;128-135
209. Mugnani E., Oertel W.H. An atlas of the distribution of GABAergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. Björklund A., Hökfelt T. Handbook of chemical neuroanatomy. GABA and neuropeptides in the CNS. Part I. vol. 4:1985;436-608 Elsevier, New York
210. Thierry A.M., Deniau J.M., Herve D., Chevalier G. Electrophysiological evidence for non-dopaminergic mesocortical and mesolimbic neurons in the rat brain. Brain Res. 201:1980;210-214
211. Van Bockstaele E.J., Pickel V.M. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res. 682:1995;215-221
212. Walaas I., Fonnum F. Biochemical evidence of γ-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat. Neuroscience. 5:1980;63-72
213. Charara A., Smith Y., Parent A. Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol. 364:1996;254-266
214. Smith Y., Charara A., Parent A. Synaptic innervation of midbrain dopamine neurons by glutamate-enriched terminals in the squirrel monkey. J Comp Neurol. 364:1996;231-253
215. Frantz K., Harte M., Ungerstedt U., O'Connor W.T. A dual probe characterization of dialysate amino acid levels in the medial prefrontal cortex and ventral tegmental area of the awake freely moving rat. J Neurosci Meth. 119:2002;109-119
216. A receptors within the ventral tegmental area. Neurochem Res. 17:1992;101-106
217. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci. 12:1992;1040-1062
218. BR1 receptor mRNA and binding sites in the rat brain. J Comp Neurol. 412:1999;1-16
219. B receptors in the basal ganglia in monkeys. Neuroscience. 95:2000;127-140
220. A receptor subunits in the basal ganglia and associated limbic brain areas of the adult rat. J Comp Neurol. 433:2001;526-549
221. B receptors in midbrain monoamine containing neurons in the rat. Brain Res Bull. 56:2001;1-5
222. Johnson S.W., North R.A. Two types of neurone in the rat ventral tegmental area and their synaptic inputs. J Physiol (Lond). 450:1992;455-468
223. Lacey M.G. Neurotransmitter receptors and ionic conductances regulating the activity of neurones in substantia nigra pars compacta and ventral tegmental area. Prog Brain Res. 99:1993;251-276
224. White F.J. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci. 19:1996;405-436
225. Klitenick M.A., DeWitte P., Kalivas P.W. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 12:1992;2623-2632
226. B receptors is altered after repeated amphetamine treatment. Neuroscience. 109:2002;585-595
227. Yoshida M., Yokoo H., Tanaka T., Emoto H., Tanaka M. Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat. Brain Res. 636:1994;111-114
228. Xi Z.-X., Stein E.A. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther. 290:1999;1369-1374
229. Wu Y.-N., Shen K.-Z., Johnson S.W. Presynaptic inhibition preferentially reduces the NMDA receptor-mediated component of transmission in rat midbrain dopamine neurons. Br J Pharmacol. 127:1999;1422-1430
230. Hurley K.M., Herbert H., Moga M.M., Saper C.B. Efferent projections of the infralimbic cortex of the rat. J Comp Neurol. 308:1991;249-276
231. Carr D.B., Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci. 20:2000;3864-3873
232. Sesack S.R., Pickel V.M. Prefrontal cortical efferents in the rat synapse of unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol. 320:1992;145-160
233. Bonci A., Malenka R.C. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells on the ventral tegmental area. J Neurosci. 19:1999;3723-3730
234. Albin R.L., Makowiec R.L., Hollingsworth Z.R., Dure L.S., Penney J.B., Young A.B. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46:1992;35-48
235. Paquet M., Tremblay N., Soghomonian J.-J., Smith Y. AMPA and NMDA glutamate receptor subunits in midbrain dopaminergic neurons in the squirrel monkey: an immunohistochemical and in situ hybridization study. J Neurosci. 17:1997;1377-1396
236. Martin L.J., Blackstone C.D., Levey A.I., Huganir R.L., Price D.L. AMPA glutamate receptor subunits are differentially distributed in rat brain. Neuroscience. 53:1993;327-358
237. Sato K., Kiyama H., Tohyama M. The differential expression patterns of messenger mRNAs encoding non-N-methyl-D-aspartate glutamate receptor subunits (GluR1-4) in the rat brain. Neuroscience. 52:1993;515-539
238. Sato K., Mick G., Kiyama H., Tohyama M. Expression patterns of a glutamate-binding protein in the rat central nervous system: comparison with N-methyl-D-aspartate receptor subunit 1 in rat. Neuroscience. 64:1995;459-475
239. Wang T., French E.D. NMDA, kainate, and AMPA depolarize nondopamine neurons in the rat ventral tegmentum. Brain Res Bull. 36:1995;39-43
240. Suaud-Chagny M.F., Chergui K., Chouvet G., Gonon F. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience. 49:1992;63-72
241. Wang T., French E.D. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat tegmental dopamine neurons. Synapse. 13:1993;270-277
242. Karreman M., Westerink B.H.C., Moghaddam B. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum. J Neurochem. 67:1996;601-607
243. Giorgetti M., Hotsenpiller G., Ward P., Teppen T., Wolf M.E. Amphetamine-induced plasticity of AMPA receptors in the ventral tegmental area: effects on extracellular levels of dopamine and glutamate in freely moving rats. J Neurosci. 21:2001;6362-6369
244. Kretschmer B.D. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors. J Neurochem. 73:1999;839-848
245. Chergui K., Charlety P.J., Akaoka H., Saunier C.F., Brunet J.L., Buda M., Svensson T.H., Chouvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci. 5:1993;137-144
246. Feenstra M.G.P., Botterblom M.H.A., van Uum J.F.M. Local activation of metabotropic glutamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic receptors. J Neurochem. 70:1998;1104-1113
247. Takahata R., Moghaddam B. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J Neurochem. 75:2000;1775-1778
248. Svensson T.H., Mathé J.M., Nomikos G.G., Schilström B. Role of excitatory amino acids in the ventral tegmental area for central actions of non-competitive NMDA-receptor antagonists and nicotine. Amino Acids. 14:1998;51-56
249. Takahata R., Moghaddam B. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex. J Neurochem. 71:1998;1443-1449
250. Johnson S.W., Seutin V., North R.A. Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump. Science. 258:1992;665-667
251. Zheng F., Johnson S.W. Group I metabotropic glutamate receptor-mediated enhancement of dopamine cell burst firing in rat ventral tegmental area in vitro. Brain Res. 948:2002;171-174
252. French E.D., Ferkany J., Abreu M., Levenson S. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. Neuropharmacology. 30:1991;1039-1046
253. French E.D. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons. Eur J Pharmacol. 271:1992;1-7
254. French E.D., Mura A., Wang T. MK-801, phencyclidine (PCP) and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive antagonists. Synapse. 13:1993;108-116
255. Murase S., Mathé J.M., Grenhoff J., Svensson T.H. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization. J Neural Transm Gen Sect. 91:1993;13-25
256. French E.D. Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol Teratol. 16:1994;355-362
257. 2A receptor blockade. J Pharmacol Exp Ther. 277:1996;1541-1549
258. Yan Q.S., Reith M.E.A., Jobe P.C., Dailey J.W. Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats. Brain Res. 765:1997;149-158
259. Murase S., Grenhoff J., Chouvet G., Gonon F.G., Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci Lett. 157:1993;53-56
260. Mathé J.M., Schilström B., Nomikos G.G., Svensson T.H. Non-NMDA receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J Neurosci Res. 51:1998;583-592
261. Ohishi H., Akazawa C., Shigemoto R., Nakanishi S., Mizuno N. Distributions of the mRNAs for L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in the rat brain. J Comp Neurol. 360:1995;555-570
262. Kinoshita A., Shigemoto R., Ohishi H., van der Putten H., Mizuno N. Immunohistochemical localization of metabotropic glutamate receptors, mGluR7a and mGluR7b, in the central nervous system of the adult rat and mouse: a light and electron microscopic study. J Comp Neurol. 393:1998;332-352
263. Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J Comp Neurol. 322:1992;121-135
264. Ohishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study. J Comp Neurol. 335:1993;252-266
265. Ohishi H., Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience. 53:1993;1009-1018
266. Romano C., Sesma M.A., McDonald C.T., O'Malley K., van den Pol A.N., Olney J.W. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain. J Comp Neurol. 355:1995;455-469
267. Petralia R.S., Wang Y.-X., Niedzielski A.S., Wenthold R.J. The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations. Neuroscience. 71:1996;949-976
268. Mercuri N.B., Stratta F., Calabresi P., Bernardi G. Electrophysiological evidence for the presence of ionotropic and metabotropic excitatory amino acid receptors on dopaminergic neurons of the rat mesencephalon: an in vitro study. Funct Neurol. 7:1992;231-234
269. Mercuri N.B., Stratta F., Calabresi P., Bonci A., Bernardi G. Activation of metabotropic receptors induces an inward current in rat dopamine mesencephalic neurons. Neuroscience. 56:1993;399-407
270. Shen K.Z., Johnson S.W. A slow excitatory postsynaptic current mediated by G-protein-coupled metabotropic glutamate receptors in rat ventral tegmental dopamine neurons. Eur J Neurosci. 9:1997;48-54
271. Zhang X.F., Hu X.T., White F.J., Wolf M.E. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther. 281:1997;699-706
272. Rossetti Z.L., Marcangione C., Wise R.A. Increase of extracellular glutamate and expression of Fos-like immunoreactivity in the ventral tegmental area in response to electrical stimulation of the prefrontal cortex. J Neurochem. 70:1998;1503-1512
273. Gariano R.F., Groves P.M. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res. 462:1988;194-198
274. Chergui K., Suaud-Chagny M.F., Gonon F. Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience. 62:1994;641-645
275. Tong Z.-T., Overton P.G., Clark D. Stimulation of the prefrontal cortex in the rat induces patterns of activity in midbrain dopaminergic neurons which resemble natural events. Synapse. 22:1996;195-208
276. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J Neurosci. 15:1995;3896-3904
277. Taber M.T., Das S., Fibiger H.C. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. J Neurochem. 65:1995;1407-1410
278. You Z.B., Tzschentke T.M., Brodin E., Wise R.A. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. J Neurosci. 18:1998;6492-6500
279. Fuster J.M. The prefrontal cortex: anatomy, physiology and neuropsychology of the frontal lobe. 1997;Lippincott/Raven, Philadelphia
280. Azmitia E.C., Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 179:1978;641-668
281. Phillis J.W. Microiontophoretic studies of cortical biogenic amines. Descarries L., Reader T.R., Jasper H.H. Monoamine innervation of cerebral cortex. 1984;175-194 Alan Liss, New York
282. Kosofsky B.E., Molliver M.E. The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse. 1:1987;153-168
283. Durstewitz D., Seamans J.K., Sejnowski T.J. Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex. J Neurophysiol. 83:2000;1733-1750
284. Lewis B.L., O'Donnell P. Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential up states in pyramidal neurons via D(1) dopamine receptors. Cereb Cortex. 10:2000;1168-1175
285. Groenewegen H.J., Uylings H.B. The prefrontal cortex and the integration of sensory, limbic and autonomic information. Prog Brain Res. 126:2000;3-28
286. 1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. J Neurochem. 87:2003;831-842
287. A, and glutamate receptors. J Neurosci. 21:2001;9917-9929